Advertisement

Nimbus Discovery LLC, a computational technology-based drug discovery firm in Cambridge, has closed a $24 million Series A funding round, co-led by Atlas Venture, SR One and Lilly Ventures. Microsoft Corp. founder Bill Gates returned to participate in funding as well.

The $24 million is expected to support Nimbus’ IRAK4 and ACC programs to treat inflammation, cancer and metabolic diseases, per a Nimbus news release.

SOURCE

SOURCE

Advertisement
Advertisement